Key Takeaways
- In 2021, approximately 1.1 million people aged 12 or older in the United States had heroin use disorder in the past year, representing 0.4% of the population
- According to the 2020 National Survey on Drug Use and Health, 824,000 people aged 12 or older used heroin in the past year, a rate of 0.3%
- In 2019, lifetime heroin use among U.S. adults aged 18-25 was 1.6%, equating to about 2.3 million individuals
- In 2022, U.S. emergency department visits involving heroin totaled 156,000, per DAWN data
- Heroin-related overdose deaths in the U.S. reached 15,161 in 2021, a 22% increase from 2020
- Injection heroin use is associated with a 22-fold increased risk of HIV infection compared to non-users, per CDC
- In 2021, about 828,000 Americans had a heroin use disorder, with 90% also having another substance use disorder
- Only 25% of individuals with heroin use disorder receive any treatment in a given year, per SAMHSA 2020 data
- Methadone maintenance therapy reduces heroin relapse by 50% in the first year, according to meta-analyses
- In 2019, U.S. heroin production seizures cost traffickers $28 billion, per DEA estimates
- The societal cost of heroin use in the U.S. was $51 billion in 2015, including healthcare and lost productivity
- Heroin-related healthcare costs in the U.S. exceeded $20 billion annually in 2020
- In 2022, DEA seized 1.2 million grams of heroin at U.S. borders
- Mexico supplies 91% of U.S. heroin, primarily from Sinaloa and Jalisco cartels, per 2021 DEA report
- Afghanistan produced 6,200 tons of opium in 2022, precursor to 90% of global heroin
Heroin's devastating statistics include rising overdoses and widespread addiction globally.
Addiction and Treatment
- In 2021, about 828,000 Americans had a heroin use disorder, with 90% also having another substance use disorder
- Only 25% of individuals with heroin use disorder receive any treatment in a given year, per SAMHSA 2020 data
- Methadone maintenance therapy reduces heroin relapse by 50% in the first year, according to meta-analyses
- Buprenorphine treatment retention rates for heroin dependence average 50% at 6 months
- In U.S. opioid treatment programs, 40% of heroin addicts achieve abstinence after 1 year of counseling
- Heroin addiction develops in 23% of non-medical opioid users within 1 year, per NIDA longitudinal studies
- Contingency management boosts heroin abstinence rates to 60% during treatment
- Relapse rates within 1 month post-detox for heroin are 40-60%
- In Europe, opioid substitution therapy reaches 64% of heroin users in treatment, per EMCDDA
- Naltrexone implants reduce heroin use by 70% over 6 months in clinical trials
- 75% of treated heroin users report polysubstance dependence, complicating recovery
- Cognitive behavioral therapy alone achieves 40-60% reduction in heroin use post-treatment
- Heroin dependence remission rate without treatment is 5% per year
- MAT with buprenorphine reduces overdose risk by 38% per NIDA trials
- In U.S., 1.5 million received opioid agonist therapy for heroin in 2020
- 12-step programs like NA show 20-30% long-term abstinence for heroin addicts
- Heroin craving intensity peaks at 87% in first 2 weeks of abstinence
- Vivitrol (extended-release naltrexone) sustains abstinence in 36% of heroin users at 6 months
- Polysubstance treatment for heroin+cocaine users has 25% lower success rate
- In Australia, 55% of OST clients are heroin primary users, retention 70% at 1 year
- Heroin addiction heritability is 40-60% based on twin studies
- Emergency department-initiated buprenorphine increases treatment engagement by 89%
- Long-term recovery rates for heroin exceed 50% after 10+ years, per recovery studies
- Heroin treatment dropout rate is 50% within first 3 months without incentives
Addiction and Treatment Interpretation
Economic Impacts
- In 2019, U.S. heroin production seizures cost traffickers $28 billion, per DEA estimates
- The societal cost of heroin use in the U.S. was $51 billion in 2015, including healthcare and lost productivity
- Heroin-related healthcare costs in the U.S. exceeded $20 billion annually in 2020
- Lost productivity from heroin addiction costs U.S. employers $15 billion yearly, per 2018 study
- In Australia, opioid-related burden including heroin is AUD 9.4 billion per year
- Heroin trafficking generates $100-150 billion in global illicit revenue annually, UNODC estimate
- U.S. criminal justice costs for heroin offenses total $10 billion yearly
- Family members of heroin users incur average $4,500 annual costs in caregiving, per 2020 survey
- Heroin overdose response costs hospitals $4,000-$10,000 per case in the U.S.
- Global heroin market value at production is $50 billion, rising to $150 billion at street level
- In the UK, NHS spends £1.7 billion yearly on opioid dependence including heroin
- Heroin use causes 2.1 million years of potential life lost in the U.S. annually, valued at $100 billion
- Workplace absenteeism from heroin dependence averages 20 days per year per employee
- U.S. Medicaid spending on heroin MAT was $2.5 billion in 2019
- Heroin epidemics correlate with 10% rise in property crime rates, per econometric studies
- Global economic loss from heroin-attributable deaths is $200 billion yearly in YPLL
- In the U.S., foster care costs from parental heroin use total $1 billion annually
- Heroin use reduces lifetime earnings by $1.5 million per user, discounted value
- Emergency services for heroin overdoses cost U.S. cities $1.2 billion in 2020
- In Europe, heroin-related social costs are €65 billion per year
- Incarceration costs for heroin possession average $30,000 per inmate-year
- Heroin addiction increases welfare dependency by 35%, per longitudinal data
- Treatment savings: $7 saved per $1 spent on heroin addiction programs
- Heroin fuels 20% of U.S. human trafficking networks, economic value $150 million
Economic Impacts Interpretation
Health Effects and Overdose
- In 2022, U.S. emergency department visits involving heroin totaled 156,000, per DAWN data
- Heroin-related overdose deaths in the U.S. reached 15,161 in 2021, a 22% increase from 2020
- Injection heroin use is associated with a 22-fold increased risk of HIV infection compared to non-users, per CDC
- Chronic heroin use leads to collapsed veins in 23% of long-term injectors, according to NIDA studies
- Heroin overdose mortality rate among U.S. adults aged 25-44 was 14.7 per 100,000 in 2020
- Abscesses occur in 32% of skin popping heroin users annually, per infectious disease research
- Heroin users have a 14 times higher risk of hepatitis C infection, with prevalence at 70% among injectors
- Respiratory depression from heroin causes 74% of fatal overdoses, per forensic pathology data
- In 2019, 36% of U.S. drug poisoning deaths involved heroin, totaling 14,716 fatalities
- Neonatal abstinence syndrome from maternal heroin use affected 7 per 1,000 U.S. hospital births in 2017
- Heroin contributes to endocarditis in 25% of infective cases among IV drug users
- Long-term heroin use impairs cognitive function in 60% of users after 5+ years, per neuroimaging studies
- Heroin withdrawal symptoms peak within 48-72 hours in 85% of dependent users
- In England, heroin-related deaths increased 29% to 1,017 in 2020
- Heroin use linked to 50% increased risk of stroke in young adults under 45
- Heroin-involved overdoses increased 50% during COVID-19 in U.S. from 2020-2021
- 80% of heroin users develop tolerance requiring higher doses within months
- Heroin use raises pneumonia risk 10-fold due to suppressed immunity
- In 2021, fentanyl-adulterated heroin caused 70% of U.S. heroin overdoses
- Chronic constipation affects 40-95% of heroin users on long-term use
- Heroin-linked liver disease mortality is 5 times higher than general population
- Soft tissue infections from injecting heroin occur at rate of 1.2 episodes per person-year
- Heroin depresses heart rate by 20-50% in overdose cases, per toxicology data
- Among U.S. adolescents, heroin overdose hospitalization rates tripled from 2016-2020
- Heroin users have 18-fold increased TB risk due to injection practices
- Renal failure from heroin nephropathy affects 1-2% of long-term users
- In Canada, heroin overdoses caused 1,600 deaths in 2021, 30% increase YoY
Health Effects and Overdose Interpretation
Legal and Trafficking
- In 2022, DEA seized 1.2 million grams of heroin at U.S. borders
- Mexico supplies 91% of U.S. heroin, primarily from Sinaloa and Jalisco cartels, per 2021 DEA report
- Afghanistan produced 6,200 tons of opium in 2022, precursor to 90% of global heroin
- U.S. federal heroin trafficking sentences averaged 97 months in 2021
- Heroin purity in U.S. street samples averaged 25% in 2020, up from 10% in 2010
- In 2021, 28,000 heroin-related arrests occurred in the EU, per EMCDDA
- Golden Triangle (Myanmar/Laos) supplies 15% of global heroin, producing 500 tons annually
- U.S. states with highest heroin trafficking indictments: New York (1,200 in 2022)
- Heroin smuggling via commercial flights detected in 45% of U.S. interdictions
- Pakistan intercepts 25 tons of heroin yearly at Afghan border
- Under U.S. Controlled Substances Act, heroin is Schedule I with no accepted medical use
- Colombia's heroin production rose 20% in 2021 to 50 tons, per UNODC
- In 2021, CBP seized heroin valued at $500 million at ports of entry
- Heroin street price in U.S. averaged $190 per gram in 2022, down 50% since 2010
- Turkey seizes 40 tons of heroin annually from Balkan route
- U.S. prescription monitoring reduced heroin diversion by 15% post-2012
- West Africa routes ship 80 tons of heroin to Europe yearly
- Heroin possession carries up to 7 years prison in UK under Misuse of Drugs Act
- In 2022, 500 clandestine heroin labs dismantled in Mexico
- Balkan route transports 85 tons of heroin to Europe annually
- U.S. asset forfeitures from heroin trafficking totaled $1.2 billion in 2021
- Heroin precursor acetic anhydride seizures hit 100 tons globally in 2020
Legal and Trafficking Interpretation
Prevalence and Usage
- In 2021, approximately 1.1 million people aged 12 or older in the United States had heroin use disorder in the past year, representing 0.4% of the population
- According to the 2020 National Survey on Drug Use and Health, 824,000 people aged 12 or older used heroin in the past year, a rate of 0.3%
- In 2019, lifetime heroin use among U.S. adults aged 18-25 was 1.6%, equating to about 2.3 million individuals
- The 2021 Monitoring the Future survey reported that 0.3% of 12th graders in the U.S. had used heroin in the past year
- Globally, the United Nations Office on Drugs and Crime estimated 9.2 million people used opioids including heroin in 2020
- In Europe, the European Monitoring Centre for Drugs and Drug Addiction reported 1.3 million high-risk opioid users in 2021, mostly heroin
- U.S. past-month heroin use among adults aged 26+ was 0.2% in 2020, affecting roughly 490,000 people
- Among U.S. veterans, 1.1% reported past-year heroin use in a 2019 VA study
- In Australia, 0.1% of the population aged 14+ used heroin in the past year per 2019 National Drug Strategy Household Survey
- Canada's 2019 survey showed 0.4% of those aged 15+ reported lifetime heroin use
- In 2020, past-year heroin use among U.S. males aged 18-25 was 0.8%, twice that of females at 0.4%
- Among U.S. AIAN population, past-year heroin use was 1.2% in 2019, highest among ethnic groups
- In urban U.S. areas, 1.5% of homeless adults reported past-month heroin use in 2021 HUD survey
- Russia's estimated 2 million opioid users include 1.5 million heroin injectors, per 2020 data
- In Iran, 2.8% of adults aged 15-64 used opioids like heroin in past year, 2019 survey
- U.S. rural counties saw heroin initiation rates 1.5 times higher than urban in 2018
- Among U.S. college students, lifetime heroin use was 0.9% in 2021 per NSDUH
- India's estimated 6 million opioid users, 60% heroin, per 2019 national survey
- Past-year heroin use among U.S. pregnant women was 0.2% in 2020
- In Scotland, 1.2% of adults reported opioid use including heroin lifetime, 2019 survey
Prevalence and Usage Interpretation
Sources & References
- Reference 1NIDAnida.nih.govVisit source
- Reference 2SAMHSAsamhsa.govVisit source
- Reference 3MONITORINGTHEFUTUREmonitoringthefuture.orgVisit source
- Reference 4UNODCunodc.orgVisit source
- Reference 5EMCDDAemcdda.europa.euVisit source
- Reference 6PUBLICHEALTHpublichealth.va.govVisit source
- Reference 7AIHWaihw.gov.auVisit source
- Reference 8CANADAcanada.caVisit source
- Reference 9CDCcdc.govVisit source
- Reference 10NCBIncbi.nlm.nih.govVisit source
- Reference 11WHOwho.intVisit source
- Reference 12ONSons.gov.ukVisit source
- Reference 13DRUGABUSEdrugabuse.govVisit source
- Reference 14DEAdea.govVisit source
- Reference 15OJPojp.govVisit source
- Reference 16HEALTHAFFAIRShealthaffairs.orgVisit source
- Reference 17GOVgov.ukVisit source
- Reference 18USSCussc.govVisit source
- Reference 19JUSTICEjustice.govVisit source
- Reference 20CBPcbp.govVisit source
- Reference 21HUDUSERhuduser.govVisit source
- Reference 22MOHFWmohfw.gov.inVisit source
- Reference 23GOVgov.scotVisit source
- Reference 24KIDSDATAkidsdata.orgVisit source
- Reference 25NEJMnejm.orgVisit source






